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A b s t r a c t  
The purpose of this study was to develop and optimize oral controlled-release formulations for 
highly water soluble model drug Venlafaxine hydrochloride using a combination of hot-melt 
subcoatings based coating polymer and aqueous polymer coating. Hot melt subcoating was 
achieved by centrifugal granulator. For the polymer coating, Acrylate-based (Eudragit RS 30D and 
Eudragit NE 30D), were used. Furthermore polymer coating, the pellets were evaluated with respect 
to their ability to modulate the in-vitro release of a highly water soluble compound. By using hot 
melt subcoating, the polymer coating level of pellets was reduced by half to obtain sustained 
release profile. In this study, the release profile of pellets was found to be optimum at a 4% level of 
hot melt subcoating and 15 % level of Eudragit® NE30D polymer coating combination, consequently 
meeting the desired responses. The release profile of the pellets prepared by this technique 
satisfied the first order plot with (R  sq =0.9434) indicating the release of water soluble drug from 
porous matrices. By means of this hot-melt subcoating and polymer coating combination, sustained-
release pellets containing venlafaxine hydrochloride were successfully prepared.  
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Introduction 
The multiunit controlled release dosage forms are usually 
manufactured by coating the drug-loaded pellets or granules with 
gastrointestinal fluid-insoluble polymers . The drug release is 
controlled by diffusion through the pores of polymer film. The 
coating of particulates such as powders, granules, pellets and 
tablets to produce controlled release dosage form is becoming 
increasingly popular, mainly due to the advances in coating 
technologies as well as availability of new coating materials[1]. 
At present, pellets containing drugs with highly water soluble 
property are prepared by the melt pelletization process [2], the 
natural polymer and cross-linking technique and polymer 
subcoating.  To control the release currently, sustained-release 
method includes water-insoluble polymer coating such as ethyl 
cellulose dispersion, acrylate based dispersion, ion exchange 
resins, water insoluble or soluble matrix (i.e., stearic acid or 
HPMC), and osmotic agents forming osmotic pump[3,4,5]. 
However, the technique mentioned above can be employed in 
specific dosage forms or active ingredients with specific property. 
Extremely water soluble drugs needed higher polymer coating 
levels than poorly soluble ones, because of the migration during 
the application of the aqueous polymer dispersion [6]. This may 
create pores or channels on the surface or inner part of the pellets 
during dissolution. For compounds with this property, higher 
coating levels are required to prevent premature drug release. 
But, the hot-melt coating techniques do not necessitate the 
usage of solvents and show promising function in taste masking, 
gastric resistance, acid resistance, sustained release and 
bioavailability enhancement, based upon type of coating 
polymer[7]. In order to control the release of extremely water 
soluble drug lipophilic subcoat has been proposed [8-10]. In this 
study, instead of polymeric subcoating, melt subcoating was 
applied to retard drug release. It functions as a wall between 
the polymers coated layer and the drug-loaded pellets, and is 
projected to reduce media penetration throughout the dissolution 
[11]. The use of wax in melt coating is advantageous because wax 
is inert to most pharmaceutical active compounds and also having 
controlled release properties[12,13](. The additives, cellulose-
based or acrylate-based polymers, were investigated as the rate 
controlling substances.Therefore, in the present work, cetosteryl 
alcohol melt subcoating was carried out using a centrifugal 
granulator, where the cetosteryl alcohol was sprinkled through 
the volumetric feeder. Subsequently, water insoluble polymers, 
acrylate-based (Eudragit RS 30D and Eudragit NE 30D), were 
used for coating the pellets using fluidized bed technique. 
Although Eudragit products are true latex with low Tg's, 
particle coalescence at room temperature is still slow and 
incomplete, necessitating accelerated curing conditions and the 
incorporation of water-soluble additives   Altogether, all these 
polymers efficiently encapsulates pellets to control drug release. 
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In conclusion, The main purpose of this study is to investigate 
the effectiveness of the combination of melt subcoating and 
polymer coating and to screen the water insoluble polymer coating 
to control the drug release of an extremely water soluble agent. In 
addition, the hot-melt subcoating can enhance the function of 
polymer coating as well as the roundness of pellets, which can be 
confirmed by scanning electron microscope (SEM) photographs. 
The mechanism of drug release from pellets prepared by the 
combination of hot-melt subcoating and polymer coating was 
approached. 
Materials and Methods 
Materials 
The following chemicals were obtained from commercial suppliers 
and used for the experiment:- Venlafaxine hydrochloride (Arti 
Drugs India), Microcrystalline cellulose (Avicel PH 101, FMC 
biopolymer Nederland), Hydroxy propyl cellulose (L-HPC, Shin-
Etsu Chemical, Japan), all of EP standard. Purified water was 
used as a liquid binder. Talc (Guangxi Yulin Talc Factory) was 
used as anticohesive agent, and TEC as plasticizer (Indo-Nippon 
Chemical Co. Ltd. Mumbai). The subcoating material cetosteryl 
alcohol was procured from Cognis India. The polymer coating 
material, Acrylate-based dispersions Eudragit RS 30D and 
Eudragit NE 30D were procured from Evonik, Mumbai India. 
Core Pellets Preparation 
Pellets (0.8 ă 1.1 mm diameter) containingVanlafaxine 
Hydrochloride(as model drug), Avicel PH101 and  HPC were 
prepared by extrusion and spheronization using a bench top 
laboratory extruder model-MG 55 and spheronizer model QJ 230 
T-1 (Fuji Paudal Co. Ltd, Tokyo Japan). A wet mass was prepared 
from the powder mixture before extrusion by using water as 
granulating fluid. The spheronised pellets were dried using 
Fluidised Bed Drier (Retsch Gmbh & Co., Haan Germany, model-
TG 100) operating at 600C for 20 min in 2 sets of air speeds, 
initially minimum and then increased to avoid the 
fragmentation of pellets. 
Melt Sub coating using centrifugal granulator 
In order to control the release of Vanlafaxine HCl, which is 
extremely water soluble, hot melt sub coating technique was 
used. Cetosteryl alcohol (melting point 48 0C) was selected as 
wax for melt subcoating at the level 2%, 4% and 6%. Hot melt 
coating technique is defined as the application of a fine layer of 
coating material in molten state over the substrate.  
The wax melt subcoating was performed on centrifugal 
granulator (Granurex Freund GX-20, Freund Industrial Co., 
Ltd., Tokyo, Japan A centrifugal granulator has a rotating 
friction plate instead of a screen at the bottom of the product 
container. The inlet air was passed through an air gap between 
the rotating plate and the wall of the product container. The inlet 
temperature was set at 60 0C which was slightly higher than the 
melting point of cetosteryl alcohol and the outlet temperature 
was 400C.  The movement of the particles in the equipment is 
helical and is the result of the centrifugal force from the rotating 
plate which tends to push the material towards the wall of the 
processing chamber in addition to the fluidizing force from the air 
stream through the gap which avoids particle sticking. However, 
the force of gravity allowed the product to fall towards the centre of 
the rotor plate. Heating was continued until the bed temperature of 
the particles was above 550C. At this time, cetosteryl alcohol was 
added to the rotary fluidized bed processor. The addition of 
cetosteryl alcohol was controlled through volumetric feeder and the 
weight gained was due to the percentage buildup of the pellets 
from the core pellets. After all the cetosteryl alcohol was added, 1% 
talc was added to avoid particle aggregation because it acts as an 
anticohesive agent.  
 
Polymer coating  
The release of drug substance from the reservoir system 
depends on the thickness of polymer coating (11). In order to 
determine the coating level needed for obtaining desired controlled 
release, pellets were coated in different weight gains (10% to 20% 
w/w) of solid polymer and samples of pellets were removed at 
10%, 15 % and 20 %weight gain increments. Experiment lay 
out is mentioned in table 1. 
 
Since many polymers used for controlled drug release are 
water-insoluble, they were traditionally applied from organic 
solutions. The disadvantages of this process are explosion / 
flammability hazards, environmental considerations, risk of residual 
solvents in the polymer film and the higher viscosity of polymer 
solutions. As an alternative, aqueous dispersion of the polymers 
has been developed.   Polymer dispersion spreading on the 
surface of the pellets forms a plastic film coating. In this study, 
Acrylate-based Eudragit RS30D &Eudragit NE30D polymers were 
selected for coating. Eudragit RS30D and Eudragit NE30D are pH 
independent and insoluble, but due to their swelling in physiological 
media, are particularly well suited for controlling the drug release. 
Eudragit RS30D dispersion was prepared using TEC as plasticizer 
whereas no plasticizer was required to prepare polymeric 
dispersion of Eudragit® NE30D, due to its soft and flexible nature. 
However, talc was used as anticaking agent The polymer 
dispersion was sprayed on 500 g pellets, which had already been 
subcoated with 4 % cetosteryl alcohol. These pellets were then 
transferred to the fluidized bed coater (GPCG 1; Wurster insert; 
Glatt GmbH, Binzen, Germany) for sustained release coating. Final 
weight gain of 20% was targeted, but sampling was also performed 
at lower coating levels 10% and 15%. The process parameters 
were as follows: product temperature 23ă25ĈC, air flow rate 
80ă90 m3/h; spray rate 7 g/min, atomizing air pressure 2.0 bar; 
and spray nozzle diameter 1.0 mm. After coating, the pellets 
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Table 1 Experiment matrix  
Trial Type of Polymer (X1) % Coat of 
polymer (X2) 
RT1 Eudragir RS 30D 10 
RT2 Eudragir RS 30D 20 
RT10 Eudragir RS 30D 15 
RT11 Eudragir NE30D 10 
RT4 Eudragir NE30D 15 
RT5 Eudragir NE30D 20 
Dissolution studies 
The In vitro dissolution of all the coated pellets was determined 
using the USP apparatus I (Electrolab TDT 08L, India). The test 
was performed in 900 ml 0.1N HCl as the dissolution medium with 
the temperature maintained at 37.0 μ 0.5 ĈC, while the stirring 
speed was set at 100 rpm. Samples of about 10 ml volume each 
were collected at 1, 2, 4, 6, 8, 12 and 24 h then subsequently 
analyzed for percentage of drug release at the respective sampling 
intervals. Samples were analyzed directly or after dilution with 
the dissolution medium at 226.5 nm using a UV 
spectrophotometer (Shimadzu UV-1800 240V, Japan). 
Triplicate observations of each type of coated pellets were 
used in the data analysis.  
Scanning Electron Microscopy (SEM) 
The surface of drug pellets and coated pellets was examined 
under a scanning electron microscope (Carl Zeiss EVO 40 at 
20 KV, Germany). The pellets were mounted onto stubs using 
double sided adhesive tape.  
The mounted samples were sputter coated (Poloron SC6740) 
under an argon atmosphere with gold palladium and examined 
at 15 KV accelerating voltage. 
Result  
Influence of wax melt coating 
Hot-melt coating was used as it is more time-saving and 
cheaper than traditional film coating. This technology provided 
pellets with sustained-release characteristics. In this study, core 
pellets containing Venlafaxine hydrochloride were hot-melt coated 
with Cetosteryl alcohol at different levels i.e. 2, 4, and 6 % 
(wt/wt) of pellets, using centrifugal granulator. The amount of 
Cetosteryl alcohol in hot-melt coating layer was calculated by 
pellets weight gain. The drug release profile of pellets coated by 
the hot-melt process is illustrated in Figure 1. The results show that 
there was an inverse relationship between the thickness of the hot-
melt coating and the rate of drug release. However, when hot-melt 
coating was at the 4 and 6 % level, there was no significant 
difference observed in dissolution. Hence, further coating at high 
level was not attempted. Burst release was observed as more 
than 90% of drug was released within 1 hour, the possible 
reasons being the erosion of wax layer due to vertex flow of 
fluid and paddle movement. 
Even though hot-melt subcoating was used, it was still unable to 
reduce the drug release rate sufficiently. Therefore, it is 
recommended that the combination of melt subcoating and 
polymer coating may work when controlled drug release of an 
extremely water soluble agent is required. 
Influence of Polymer  
Spreading polymer dispersion on the surface of the pellets 






Figure 1: Influence of hot-melt coating on drug release of pellets prepared by 2% hot-melt coating weight gain;  4% hot- melt coating weight 
gain; 6 % hot-melt coating weight gain.  
 
Dissolution Profile of Ccetosteryl alcohol hotmelt coated formulation in 
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Venlafaxine HCl is extremely water soluble, and drug release from 
core pellets without any coating layer is fast, reaching 90% within 1 
h. Consequently, a polymer coating was introduced to investigate 
the effect on retarding drug release. The drug release pattern from 
the drug-loaded pellets, prepared by using different levels of 
Eudragit RS 30D was faster (Figure 2) with more than 85% of the 
drug release within 8h. The rapid dissolution from the pellets could 
be due to drug migration which occurs during the polymer coating 
process, resulting in pores or channels producing fast drug release 
profile. It may also ascribed to surface erosion and formation of 
soluble hydrogel and wherein the drug release could happen due 
to both diffusion and erosion mechanism. In acidic medium 0.1 N 
HCl at 2 hour, 4 hour and 8 hour dissolution profiles were very high 
for the formulation coated with Eudragit RS 30D showed more than 
10-30 % drug release at 4 hour. On the other hand, in formulation 
coated with Eudragit NE 30D, dissolution rates were much closer 
to the set limit 4 h (30-50%) and 8h (60-75%).The drug release 
profile for pellets prepared from Eudragit NE 30D(RT11, RT4 and 
RT5) at 10, 15, and 20% weight gain levels which were melt 
subcoated with 4 % cetosteryl alcohol is illustrated in Figure2. It 
can be seen that pellets with a melt subcoating level of 4% and a 
Eudragit NE 30D polymer coating level of 15%, achieved targeted 
profile. However, pellets with a 4% melt subcoating and a Eudragit 
NE 30D polymer coating of 10% and 20% weight gain both failed to 
satisfy the dissolution requirements. A fast drug release profile was 
observed at 10% polymer coating, whereas with 20% coating, slow 
dissolution profile was observed. This can be attributed to the 
greater thickness of polymer layer which increased the diffusional 
path length or, maybe, remnants sticking to the membrane. In 
addition, on an industrial scale, a 20% polymer coating level would 
be too high because of involving an increase in time required as 
well as increasing production costs. Consequently, the hot melt 
subcoating was selected to deal with the extremely water soluble 
drug, Venlafaxine hydrochloride. 
Kinetics and mechanism of drug release  
To determine the mechanism of drug release from the 
formulations, the data for final optimized formulation were 
subjected to various kinetics models using computer program; 
 
Figure 2: Dissolution profile of formulations in 900 ml 0.1 N HCl 
at 100 RPM in USP I apparatus.  
 
DDSolver[14]. The dissolution data were also fitted according to 
the well-known exponential equation of Peppas, which is often 
used to describe drug release behavior from polymeric systems. 
The release exponent n value for spherical particles, between 
0.43 and 0.85 shows anomalous type drug release involving the 
combination of both diffusion and erosion mechanism. 
As shown in (table 5) various kinetic models were giving linear 
relationship. The best linearity was found in first order plot (R sq 
=0.9434) indicating the release of water soluble drug from porous 
matrices.  By incorporating the first 60% of release data, 
mechanism of release can be indicated according to korsmeyer 
where n is the release exponent, an indicative of mechanism of 
drug release. ÂnÊ value between 0.45 to 0.89 indicating 
anomalous (non-Fickian) diffusion. 
Consequently, the main function of hot-melt subcoating can be 
attributed to three aspects: avoiding migration of the drug 
during polymer coating, retarding the drug release, and 
enhancing the effectiveness of polymer coating. 
 
Table 2: The various mathematical models and statistics from dissolution profile 
Parameter Zero-order Model First-order Model Higuchi Model Korsmeyer-Peppas 
Model 
R_obs-pre 0.9629  0.9933 0.9885  0.9737 
Rsqr 0.9166  0.9434 0.8211  0.9447 
Rsqr_adj 0.9166  0.9434 0.8211  0.9263 
SS 234.48  159.25 502.99  155.42 
N   0.824 
 
 
However, the release profile of the pellets prepared by a 
combination of hot melt subcoating and polymer coating 
satisfied the First-order and korsmeyer-peppas Model. It 
demonstrated that two membranes, hot melt subcoating and 
polymer coating, both play a significant role in prolonged drug 
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coat, it was controlled by the hot melt subcoating layer. 
Subsequently, polymer membrane became the main factor on 
controlling the drug release. If there is no hot melt subcoating layer, 
relying only on the polymer coating we cannot sustain drug 
release. Because of the presence of hydrophobic subcoating layer, 
dissolution medium had difficulty in wetting and crossing this 
layer. During dissolution, the medium should first pass through 
the polymer film coating layer then through the hot melt 
subcoating layer, and finally reach the core pellets and 
dissolve the drug. This result in an increased diffusion path 
length, since the drug solution has to diffuse through two 
membranes (as shown in the SEM photograph, Figure-3) before it 
dissolves in the surrounding membrane hence resulted in T-lag. In 
some cases, such as preparing pellets containing extremely water 
soluble drugs, if the polymer coating level is too high (such as 
20 % or above), hot melt subcoating would be an alternative. 
 
 
Figure: 3: SEM photograph of a pellet hot-melt subcoating level of 4% and A) polymer coating 15% weight gain B) 20% weight gain.. 
 
Conclusion 
The results presented in the paper revealed that hot melt 
subcoating with cetosteryl alcohol enhances the effectiveness of 
polymer coating, avoids the migration of drug during polymer 
coating, and sustains drug release. It is a new way of reducing the 
release rate of extremely water soluble drugs. Drugs with high 
water solubility can be prepared as sustained-release dosage by 
using the hot-melt subcoating process. Formulation Trial RT 4 with 
a 4 % hot-melt subcoating level and a polymer coating with 
Eudragit® NE30D at the 15 % level met the desired drug 
release requirements. The release profile of the pellets prepared 
by this technique satisfied the first order plot (R  sq =0.9434) 




drug from porous matrices.  By means of this hot-melt 
subcoating and polymer coating combination, sustained-
release pellets containing venlafaxine hydrochloride were 
successfully prepared. 
Acknowledgments 
The authors wish to thank Singhania University Pacheri Bari 




References   
[1]. Bechgaard, H, Nielsen GH.  Controlled-
Release Multiple-Units and Single-Unit 
Doses. Drug DevInd Pharm. 1978; 4: 
53-57. 
[2]. Hamdani J, Moes AJ, Amighi K. 
Development and evaluation of 
prolonged release pellets obtained by 
the melt pelletization process. Int. J. 
Pharm. 2002; 245: 167ă177. 
[3]. Sadeghi, F, Ford JL, Rubinstein M H, 
RajabiSiahboomi AR. Comparative 
study of drug release from pellets coated 
with HPMC or surelease. Drug DevInd 
Pharm.2000; 26: 651ă660. 
[4]. Porter C. Controlled-release film 
coatings based on ethylcellulose. Drug 
DevInd Pharm.1989; 15: 1495-1521. 
[5]. Wesseling M, Bodmeier R. Drug release 
from beads coated with an aqueous 
colloidal ethylcellulose dispersion, 
Aquacoat®, or an organic ethylcellulose 
Tiwari et al. International Journal of Drug Delivery 5 (2) 131-136 [2013] 
 
PAGE | 136 |
 
 
solution. Eur J Pharm Biopharm. 1999; 
47:33ă8. 
[6]. Frenning, G, Tunon A, Alderborn G. 
Modelling of drug release from coated 
granular pellets. J Control  Rel. 2003; 
92: 113ă123.  
[7]. Lee S, Kim MS, Jun SW, Park JS, 
Hwan, SJ. Preparation and controlled 
release spheronized beads by a simple 
extrusion and modified spheronization 
process. Arch  Pharm Res. 2005; 28; 
619ă625. 
[8]. Barthelemy P, Laforet JP, Farah N, 
Joachim J. Compritol 888 ATO: an 
innovative hot melt coating agent for 
prolonged drug formulations. Eur J 
Pharm Biopharm. 1999; 47:87-90.  
[9]. Bruce LD, Koleng JJ, McGinity JW. The 
influence of polymeric subcoats and 
pellet formulation on the release of 
chlorpheniramine maleate from enteric 
coated pellets. Drug DevIndPharm. 
2003; 29: 909ă924. 
[10]. BruceLD, Petereit HJ, Beckert T, 
McGinty JW. Properties of enteric 
coated sodium valproate pellets. Int. J. 
Pharm.2003; 264: 85ă96. 
[11]. Sato H, Miyagawa Y, Okabe T, 
Miyajima, M, Sunada H. Dissolution 
mechanism of diclofenac sodium from 
wax matrix granules. JPharm Sci. 1997; 
86: 929-934. 
[12]. Heng, PWS, Hao J, Chan LW, Chew 
SH. Influences of osmotic agents in 
diffusion layer on drug release from 
multilayer coated pellets. Drug DevInd 
Pharm. 2007; 30: 213ă220 
[13]. Miyagawa Y, Okabe T, Yamaguchi Y, 
Miyajima M, Sato H, Sunada H. 
Controlled-release of diclofenac sodium 
from wax matrix granule. Int. J. Pharm. 
1996; 138: 215-224. 
[14]. Setty CM, Bijaya G. Development and 
invitro evaluation of multiparticulate 
sustained release formulationofdiltiazem 
using ethyl cellulose and cellulose 
acetate phthalate. Indian Drug. 1998; 
35: 195 ă199. 
[15]. Yong  Z, Meirong  H, Jianping  Z, Aifeng 
Z, Weize L, Solver DD. An Add-In 
Program for Modeling and Comparison 
of Drug Dissolution Profiles. AAPS J. 
2010; 12: 263-271. 
 
